With the sale of the drug to a bigger drug company,it will free up DNDN to persue its other cancer drug which really seems to have a gigantic potential...
Sentiment: Buy
me too'
In this game when deck is stacked so much in the way this is,things will go the other way,look for short to be blown out of water.
Sure was.
Pfizer should look into the buyout of DNDN as their drug is deemed useless and Dendreon is in situation where they need either a solid partner of complete buyout'
Sentiment: Strong Buy
sounds like your probably went short at 4.50....
Sentiment: Strong Buy
It only stands to reason that if medicare is upping their payout for other drugs and services that they will do it for provenge shorts will soon be crushed'
Sentiment: Strong Buy
Elan should use stock and the money they got from Biogen to purchase DNDN,they can make this thing really happen....
Sentiment: Strong Buy
Look for buyout as they are really build out their anti cancer process. Novatis could make a bid shortly'
Sentiment: Buy
second that motion
Sentiment: Buy
Everyone in the know seems to know they are either looking for a partner or possibly a buyout....I'm sure they know they can't go it alone by now....Shorts could really get burned here in the near future.
Sentiment: Buy
Now that the suit is resolve they have to know they have to partner with someone or be bought out....J&J should be willing to pay 12 dollars for the company that is what it is really worth right now.
Sentiment: Buy
John was more of a wheeler dearler type and was probably eyeing another aquisition,they have a good franchise thanks to him but he doesn't seem to be a real banker in the sense of the word...They can now apply the principle that made them a good bank in the first place.....They have to be worth 13 to 14 dollars on a buyout right now...Good move First Niagra'
Sentiment: Strong Buy